Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455985 · ClinicalTrials.gov registry record · NA
Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin
A NA study, sponsored by Ohio State University.
- Terminated
- Registry status
- NA
- Development phase
- 158
- Enrollment target
NCT03455985 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 158 participants.
The verdict
NCT03455985, a NA study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
Study Summary
Diabetes is present in 25% of hospitalized patients; yet effective hospital discharge programs for patients with diabetes are understudied. In particular, patients who are initiating or intensifying insulin therapy have the most to benefit in terms of glycemic control. However, these patients are also particularly vulnerable to poor transitions of care for a variety of reasons, including the complexity of therapy, inadequate patient education, differences in patient and provider expectations, and insufficient resources. Disruption of insulin therapy following hospitalization is associated with higher HbA1c, shorter survival, and increased readmissions and medical costs. In a Society of Hospital Medicine Survey, only one fourth of hospitals were supported with written protocols to standardize medication, education, equipment, and follow-up instructions. However, discharge order sets have largely been limited to the inpatient setting and have not been utilized to guide insulin use at hospital discharge. This study will assess whether a nurse supported diabetes focused inpatient discharge order set (DOS) can improve post-discharge outcomes among hospitalized patients with poorly controlled insulin-requiring diabetes.
Interventions
- OTHER Discharge Order Set (DOS)
- OTHER Enhanced Standard Care (ESC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2020-09-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03455985
The ClinicalTrials.gov registry entry for NCT03455985 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 158 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Discharge Order Set (DOS) is the first listed.
NCT03455985 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03455985 about?
NCT03455985 is a clinical study titled "Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin". Diabetes is present in 25% of hospitalized patients; yet effective hospital discharge programs for patients with diabetes are understudied. In particular, patients who are initiating or intensifying insulin therapy have the most to benefit in terms of glycemic control. However, these patients are al...
What is the current status of trial NCT03455985?
This trial is currently terminated. It is a NA study. The enrollment target is 158 participants. The study started on 2018-05-01. Estimated completion is 2020-09-11.
What interventions are being tested in trial NCT03455985?
The interventions under investigation include: Discharge Order Set (DOS) (OTHER), Enhanced Standard Care (ESC) (OTHER).
Who is sponsoring clinical trial NCT03455985?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.